Search results for: Precision Medicine
Filter search results
Reconciling MCDA and Augmented Cost-Effectiveness Analysis: Do We Get the Same Decisions?
14 April 2021
…19, 1 – 13. Sussex, J., Rollet, P., Garau, M., Schmitt, C., Kent, A. and Hutchings, A., (2013). A pilot study of multicriteria decision analysis for valuing orphan medicines. Value…
Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic
21 April 2021
…The SC should ensure that the European Commission, the European Medicines Agency, and the Member States’ (MSs) healthcare agencies coordinate via the European Network for Health Technology Assessment (EuNetHTA), so…
Claud Theakston
26 January 2023
…and processes across countries, as well as the broader value of medicines to society and how health economics can help us respond to and prepare for challenges and demographic changes….
Mikel Berdud
26 February 2015
…research includes the analysis of the life-cycle value of medicines, social surplus created by new health technologies and its distribution, the economics of anti-microbial resistance including push and pull incentive…
Surveillance and Early Diagnosis and General Practice
1 July 1966
…extension of clinical medicine, primarily in general practice, to increase the likelihood of particular diseases being detected, whether the patient as consulted the doctor for that disease or not. These…
Adverse Reactions and the Community
1 November 1982
…the future. Historically, two events stand out in relation to adverse reactions to medicines. The first was the thalidomide tragedy in 1961, and the second was with practolol in the…
Coronary Heart Disease: the Scope for Prevention
1 August 1982
…potential for therapeutic intervention. Beta blocking drugs in conjunction with other medicines, now provide highly effective control of anginal pain in about three-quarters of patients. For more severe cases the…
Ill in Europe
1 October 1982
…non-prescription medicines. They also claim health care insurance. In 1981, BUPA and other health insurance agencies paid out almost £205 million, or 1.5 per cent of the total expenditure. A…